Asia Pacific Cannabis Testing Market

The Asia Pacific cannabis testing market accounted to US$ 132.38 Mn in 2017 and is expected to grow at a CAGR of 15.8% during the forecast period 2018 – 2025, to account to US$ 422.74 Mn by 2025.

The Asia Pacific cannabis testing market is expected to grow at highest rate during the forecast period owing to growing adoption of LIMS, and cannabis legalization for medical and recreational purpose in Asia Pacific region.      

Exhibit: Lucrative Regional Markets

Market Insights

Growing adoption of LIMS

The growing advanced technology provide the best solutions to meet the current requirements and enables the system to be readily adapted based on the needs. The modern LIMS (Laboratory Information Management Systems) system are used to automatically registers and archives the results of laboratory work, to support people management & equipment and materials administration. Advancements including, macro level challenges to increase innovation, manage risk, improve governance, comply with regulatory requirements, and deliver quantifiable operational results, help pathology laboratories to meet the evolving demands of the modern pathology services in the region. The increasing adoption of LIMS technique helps to improve the transparency to lab work status, reducing the costs & improved efficiency, providing flexibility to accommodate new requirements and also help to improve quality & compliance. Penetration of information technology and increasing demand for data management and standardization is helping in growing the number of LIMS vendors in the market. The increasing demand for the LIMS in Asian market and R&D spends in the counties like China and India is growing that proportionally upsurge the market growth in the region.

Thus, due to the above advancements, the cannabis testing market is expected to grow at a rapid pace during the forecast period.

Cannabis legalization for medical and recreational purpose

The Asia Pacific region projects a great demand for cannabis testing market. This is because the medical use of cannabis to heal patients of various disease for example chronic neuropathic pain, and any spinal injury. It also helps to deal with anorexia in HIV AIDS which is a major challenge in this region. In December 2018, Thailand was the first country in Southeast Asia to legalize cannabis. There has been significant rise in investments in cannabis testing labs and recent law changes which have led to acceptance of marijuana and cannabis.

Thus, due to growing legalization of cannabis, the cannabis testing market is expected to grow at rapid pace.

Type Insights

In 2017, the product segment held a largest market share of 73.7% of the cannabis testing market, by type. This segment is also expected to dominate the market in 2025 owing diverse portfolio of cannabis testing products to the healthcare industry for innovations in the technologies. Moreover, the same segment is also expected to witness the highest CAGR in the market accounting to 16.1% in 2018 to 2015 owing to increasing analytical services and medicinal cannabis services in testing cannabis.

Service Insights

The Asia Pacific cannabis testing market on the basis of service is segmented into potency testing, microbial analysis, residual solvent screening, heavy metal testing, pesticide screening, terpene profiling, and genetic testing. The potency testing segment is anticipated to grow at a CAGR of 16.9% during the forecast period. Depending on the state in which testing occurs, a sample’s THC and CBD levels, along with its tetrahydrocannabinolic and cannabidolic acids are required. Other labs may opt to test samples for their CBC and CBG as well. Testing for potency involves gas or liquid chromatography for a range of matrices.

End User Insights

The testing laboratory segment held a largest market share of 49.2% of the cannabis testing market, by end user. This segment is also expected to dominate the market in 2025 owing to increasing number of diagnostic testing performed in the reference labs for the numerous diseases.

Exhibit: Cannabis Testing Market, by Type

Strategic Insights

Strategic acquisition and product launches were observed as the most adopted strategy in Asia Pacific cannabis testing industry. Few of the recent product launch and product approval are listed below:

2016: Agilent Technologies, Inc. introduced Agilent 5110 ICP-OES that allow scientists to perform faster, more precise ICP-OES analysis.

2017: SCIEX launched the X-Series Quadrupole Time of Flight (QTOF) mass spectrometry (MS) platform, X500B QTOF System.

2018: Restek and Separation Science entered into a collaboration to develop a multi-speaker eSeminar focused on testing methods and associated topics for medicinal cannabis labs.

CANNABIS TESTING – MARKET SEGMENTATION

By Type

• Products
• Software

By Service

• Potency Testing
• Terpene Profiling
• Pesticide Screening
• Residual Solvent Screening
• Heavy Metal Testing
• Microbial Analysis

By End User

• Testing Laboratories
• Drug Manufacturers
• Research Institutes

By Geography

•   Asia Pacific

• China
• India
• Japan

Company Profiles

• Agilent Technologies
• PerkinElmer, Inc.
• Shimadzu Corporation
• SCIEX
• Merck KGaA
• Restek Corporation
• Waters
• CannaSafe Analytics
• Accelerated Technology Laboratories, Inc.
• Digipath Labs

Asia Pacific Cannabis Testing Strategic Insights

Strategic insights for the Asia Pacific Cannabis Testing provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Asia Pacific Cannabis Testing Report Scope

Asia Pacific Cannabis Testing Regional Insights

The geographic scope of the Asia Pacific Cannabis Testing refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.